drugset / Trial / NCT07513207

A Study in Healthy People to Test How Vicadrostat Affects the Heart

NCT07513207

Phase 1 Active not recruiting 45 enrolled Boehringer Ingelheim
RandomizedCrossoverQuadruple-blindTreatment

Summary

The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.

Timeline

Start
2026-04-22
Primary completion
2026-07-24
Completion
2026-08-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule
Subject Vicadrostat Small molecule

Indications

No indication recorded.